Your browser doesn't support javascript.
loading
Porphyrin-Based Brain Tumor-Targeting Agents: [64Cu]Cu-porphyrin and [64Cu]Cu-TDAP.
Im, Changkeun; Ahn, Jae Hun; Farag, Ahmed K; Kim, Soyeon; Kim, Jung Young; Lee, Yong Jin; Park, Ji-Ae; Kang, Choong Mo.
Afiliação
  • Im C; Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, Korea.
  • Ahn JH; Radiological and Medico-Oncological Sciences, University of Science and Technology (UST), Seoul 01812, Korea.
  • Farag AK; Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, Korea.
  • Kim S; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim JY; Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, Korea.
  • Lee YJ; CDN isotopes, Toronto Research Chemicals, Montreal, Quebec H9R 1H1, Canada.
  • Park JA; Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, Korea.
  • Kang CM; Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS), Seoul 01812, Korea.
Mol Pharm ; 20(11): 5856-5864, 2023 11 06.
Article em En | MEDLINE | ID: mdl-37851927

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Porfirinas / Neoplasias Encefálicas / Glioblastoma Limite: Animals Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Porfirinas / Neoplasias Encefálicas / Glioblastoma Limite: Animals Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article